579 results on '"Filipovich, Alexandra H."'
Search Results
52. Allogeneic Hematopoietic Cell Transplantation for XIAP Deficiency: Survival Outcomes of 19 Patients
53. CMX001 as Therapy for Severe Adenovirus Infections in Immunocompromised Pediatric Patients: Single Center Experience in 6 Patients
54. Atypical Lymphoproliferative Syndrome Associated with STXBP2 Deficiency
55. Short Telomeres in Multiple Hematopoietic Lineages Define a Subset of Patients with Autoimmunity and Dysgammaglobulinemia
56. Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation
57. Contributors
58. Immunodeficiency and Cancer
59. Familial hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease
60. Reduced-intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward
61. Impaired immune function in children with Fanconi anaemia
62. PAX1 is essential for development and function of the human thymus
63. STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America
64. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members
65. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report
66. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: Current status and critical needs
67. Tumor immune surveillance defect of X-linked severe combined immunodeficiency is not Epstein–Barr virus specific
68. ADOLESCENT PRESENTATION OF X-LINKED LYMPHOPROLIFERATIVE DISEASE
69. Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis
70. Mutations of the hemophagocytic lymphohistiocytosis–associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis
71. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis
72. PATIENTS OF AFRICAN ANCESTRY WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SHARE A COMMON HAPLOTYPE OF PRF1 WITH A 50DELT MUTATION
73. Signalling during hypoxia in human T lymphocytes – critical role of the src protein tyrosine kinase p56Lck in the O2 sensitivity of Kv1.3 channels
74. Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis
75. Life-threatening hemophagocytic syndromes: Current outcomes with hematopoietic stem cell transplantation
76. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis
77. Hypoxia modulates early events in T cell receptor-mediated activation in human T lymphocytes via Kv1.3 channels
78. ZAP-70 Deficiency in an Autosomal Recessive Form of Severe Combined Immunodeficiency
79. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes
80. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans
81. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children – a Eurocord analysis
82. Unrelated cord blood transplantation for correction of genetic immunodeficiencies
83. New Malignant Diseases After Allogeneic Marrow Transplantation for Childhood Acute Leukemia
84. Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels
85. Hemophagocytic lymphohistiocytosis
86. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members
87. Hemophagocytic lymphohistiocytosis: A lethal disorder of immune regulation
88. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
89. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation
90. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program
91. T-Cell Receptor Analysis in Omenn's Syndrome: Evidence for Defects in Gene Rearrangement and Assembly
92. Immunoreconstitution by Bone Marrow Transplantation Decreases Lymphoproliferative Malignancies in Wiskott-Aldrich and Severe Combined Immune Deficiency Syndromes
93. Activated phosphoinositide 3-kinase δ syndrome in a patient with a former diagnosis of common variable immune deficiency, bronchiectasis, and lymphoproliferative disease
94. Reduced-Intensity Conditioning Hematopoietic Cell Transplantation Is an Effective Treatment for Patients with SLAM-Associated Protein Deficiency/X-linked Lymphoproliferative Disease Type 1
95. Erratum to “Bortezomib for Refractory Autoimmunity in Pediatrics” [Biol Blood Marrow Transplant 2014;20(10):1654-1659]
96. Novel Mutation in Syntaxin-Binding Protein 2 (STXBP2) Prevents IL-2-induced Natural Killer Cell Cytotoxicity
97. Accuracy of flow cytometric perforin screening for detecting patients with FHL due to PRF1 mutations
98. Pathogenesis of Hemophagocytic Lymphohistiocytosis
99. Changes in Health-Related Quality of Life in Patients with Primary Immunodeficiency Disorder (PIDD) Between Time of Diagnosis and 12 Months after Initiation of Immunoglobulin (Ig) Therapy
100. Newborn Screening for Severe Combined Immunodeficiency (SCID) in Ohio: Using Algorithms to Standardize Follow-up Limits the Number of False Positive Results
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.